WO1995029200A1 - Easily degradable star-block copolymers - Google Patents
Easily degradable star-block copolymers Download PDFInfo
- Publication number
- WO1995029200A1 WO1995029200A1 PCT/US1995/003014 US9503014W WO9529200A1 WO 1995029200 A1 WO1995029200 A1 WO 1995029200A1 US 9503014 W US9503014 W US 9503014W WO 9529200 A1 WO9529200 A1 WO 9529200A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- star
- polylactide
- block copolymer
- polycaprolactone
- lactide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
Definitions
- thermoplastics are in theory recyclable, but are often not recycled because of the cost of collecting, sorting and purifying the recycled plastics. Therefore, most plastics and other polymers such as elastomers, are disposed of with other trash, such as in landfills, where they are very chemically stable, and degrade minimally.
- One way of reducing the amount of stable polymers in landfills and the like is to produce polymers which are degradable, as by hydrolysis, biodegradation, or like processes. It is known that under the proper conditions, polylactide is biodegradable, and polymers containing this repeat unit have been considered desirable for this reason. However, most polylactide polymers are plastics, that is their glass transition temperature (Tg) is above room temperature, and they may be crystalline. Polymers which contain lactide repeat units but yet have elastomeric-like properties would also be desirable.
- Tg glass transition temperature
- U.S. Patent 5,210,108 describes foam made from a star shaped polymer containing lactide repeat units. The foams produced are rigid, not elastomeric.
- This invention concerns, a star-block copolymer, consisting essentially of, a core, 3 to about 20 inner arms of polycaprolactone which are bound to said core, and polylactide outer arms bound to said inner arms, and provided that: said polylactide is at least 50% by weight of said copolymer; said polycaprolactone is about 10% to about
- said copolymer 50% by weight of said copolymer; said polycaprolactone and said polylactide do not crystallize upon melt processing; and said polylactide has a glass transition temperature of less than 35°C.
- the instant copolymer is a star-block copolymer which contains polycaprolactone and polylactide blocks.
- the copolymer also contains a core, which is often the "starting point" for the copolymer.
- the core is originally a multi-functional material usually containing the same number of functional groups as arms which the star copolymer is meant to have.
- functional group in this instance is meant a group which either by itself, or by a reaction of the group, forms a site for the initiation of one copolymer chain (an arm of the star) . In this case it will initiate the polymerization of caprolactone.
- Suitable functional groups for the core include hydroxyl, amino, and sulfhydryl.
- caprolactone may be used in standard ways to initiate the polymerization of caprolactone.
- a catalyst such as stannous octoate may be used.
- Such polymerizations are described in European Patent Application 117,538, which is hereby included by reference.
- the polymerization may be done neat (no solvent)-or with a solvent present.
- the polycaprolactone herein is formed from epsilon- caprolactone, which is the monomer.
- the polycapro- lactone forms the "inner arm" of the copolymer herein.
- An inner arm is the polymer which is attached or bonded to the core. Since the Tg of polycaprolactone is quite low (below 0°C) this property does not generally affect the rigidity of the product of the invention. However, polycaprolactone does partially crystallize if the molecular weight is high enough. Therefore, the molecular weight of the polycaprolactone blocks should be low enough so that such crystallization does not take place upon melt processing.
- a useful molecular weight range for the polycaprolactone inner arm is a number average molecular weight of about 800 to about 4000. It is preferred if the polycaprolactone is about 10% to about 40% by weight of the copolymer, more preferred if it is about 15% to about 30%, and especially preferred if it is about 18% to about 22% by weight of the copolymer.
- the end group is normally a hydroxyl group, which can be used to help initiate the polymerization of lactide. Therefore, the lactide polymer block becomes bound (attached) to the end of the polycaprolactone block, and herein this is called the outer arm. Lactide in the D, L, or meso forms, or any combination thereof, may be used to form the polylactide block. Lactide homopolymer is semi- crystalline, and has a Tg of about 55-60°C. Therefore the polylactide block should be small enough (low in molecular weight) so that the Tg is 35°C or less, preferably 30°C or less. A typical useful range of polylactide block sizes is about 1,000 to about 12,000 in number average molecular weight, but this will vary somewhat with the size of the polycaprolactone block.
- each polylactide block is about 3,000 or more. It is also preferred if the polylactide is at least 70% by weight of the copolymer.
- the polylactide block is formed by the polymerization of lactide itself.
- This polymerization can be carried out in a number of ways, but it is usually done with a catalyst.
- Stannous octoate is a useful catalyst, but preferred catalysts are selected rare earth metal compounds, such as those disclosed in U.S. Patents 5,028,667 and 5,292,859, which are both hereby included by reference. The catalysts disclosed in the latter patent are especially preferred.
- These polymerizations are carried out neat or with solvent present, but neat (no solvent present) polymerizations are preferred. Polymerization temperatures are not critical, and 0°C to about 200°C is a convenient range.
- the polymerization of the caprolactone and lactide can be done in sequential steps in the same reactor, or the polycaprolactone (attached to the core) star polymer may be isolated and then mixed with lactide to be polymerized to form the final copolymer.
- the star-block copolymers herein have 3 to 20 arms, preferably 3 to 10 arms, more preferably 3 to 6 arms, and especially preferably 4 arms.
- the copolymers described herein are relatively tough, elastomeric-like materials that are suitable for many uses.
- liquid food packaging such as milk pouches, juice pouches, coatings for coated board for refrigerated liquids, and processed meat wrap
- dry food packaging such as the outer wrap for boxed foods, as part of a multilayer packaging film, and as the coating on coated board for frozen foods
- coating for coated board for fast food such as for drink cups
- other consumer products such as non-woven absorbants for diapers, soft pliable backsheet for diapers, film overwrap for toiletries and personal care products
- agricultural products such as mulch film
- medical products such as pliable wound dressings and low modulus surgical implants
- as a toughening additive for other polymers such as polymers used for foams or blow molding and a modifier for polymer to be spun into fibers for improved elongation and tenacity
- other uses such as adhesives, film overwrap for animal feed supplements, and artificial snow.
- the copolymer disclosed herein is particularly useful in these applications because of its biodegradability, toughness, tear strength and soft feel.
- the copolymers herein should not be crystalline, i.e., should not have a melting transition of greater than 3 J/g when tested by Differential Scanning calorimetry (see test for Tg below) upon melt processing.
- the sample for such a test is prepared by injection molding some of the copolymer in question into a 3.2 mm thick plaque, with the mold temperature being about 10°C, and the copolymer having a melt temperature (exiting the screw barrel) of about 150°C.
- the average molecular weight of a polylactide outer arm is the number average molecular weight of the copolymer times the weight fraction of polylactide in the copolymer divided by the nominal number of arms in the copolymer.
- the average molecular weight of the polycaprolactone inner arm is the number average molecular weight of the copolymer times the weight fraction of polycaprolactone in the copolymer divided by the nominal number of arms in the copolymer.
- the glass transition temperature (Tg) of the copolymer (particularly the polylactide blocks) is measured by the following procedure.
- Mn is number average molecular weight and Mw is weight average molecular weight.
- GENERAL ANALYTIC L DETAILS Molecular weights were measured using size exclusion chromatography (SEC, GPC) in THF solvent at 25°C using polystyrene calibration standards. Residual lactide monomer and total caprolactone contents are measured using 1 H-NMR at 300 MHz. Physical properties were measured using a Laboratory Microsystems tester at 9.1 kg full scale load range and a crosshead speed of 5.1 cm per minute. The reported values are the mean of at least five determinations. Film samples
- Tg was 19°C.
- Mn was 39,000, and Mw/Mn was 1.6.
- TEM 3.5 MPa, 210%, 82.7 MPa.
- EXAMPLE 3 Synthesis of 20% Caprolactone 3-Arm Star Block Polylactide Ten g polycaprolactone triol (Lot #16874-95 from Union Carbide, Mn 5260), 38.4 g L-Lactide and 1.6 g of D,L-Lactide were charged under argon to a carefully dried Helicone® C2V mixer (Atlantic Research Corp.), held at 167°C .
- Lactide conversion and caprolactone content by 1 H-nmr were 95.1, and 22% respectively, and Tg was 18°C.
- Mn was 34,200 and Mw/Mn was 1.3.
- TEM 13.1 MPa, 94%, 351 MPa.
- Lactide conversion and caprolactone content by 1 H-nmr were 92.8, and 25% respectively, and Tg was 16°C.
- Mn was 32,200 and Mw/Mn was 1.3.
- TEM 9.7 MPa, 84%, 214 MPa.
- Lactide conversion and caprolactone content by ⁇ -H-nmr were 94.8, and 21% respectively, and Tg was 23°C, Mn was 38,300 and Mw/Mn was 1.4.
- TEM 14.5 MPa, 316%, 503 MPa.
- EXAMPLE 9 Synthesis of 20% Caprolactone 4-Arm Star Block Polylactide (Tin Octoate Catalyst)
- One g polycaprolactone tetrol Lit #17360-10 from Union Carbide, Mn 7240
- 4 g L-Lactide were charged to a flame-dried Pyrex® test tube in a nitrogen filled glove-box, capped with rubber septa, and heated in a vapor bath at 166°C.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7527629A JPH09512571A (en) | 1994-04-21 | 1995-03-13 | Star-block copolymers that are easy to decompose |
EP95912859A EP0756608A1 (en) | 1994-04-21 | 1995-03-13 | Easily degradable star-block copolymers |
MX9604958A MX9604958A (en) | 1995-03-13 | 1995-03-13 | Easily degradable star-block copolymers. |
AU19883/95A AU1988395A (en) | 1994-04-21 | 1995-03-13 | Easily degradable star-block copolymers |
FI964217A FI964217A0 (en) | 1994-04-21 | 1996-10-18 | Slightly falling star-block polymers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/230,994 | 1994-04-21 | ||
US08/230,994 US5399666A (en) | 1994-04-21 | 1994-04-21 | Easily degradable star-block copolymers |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995029200A1 true WO1995029200A1 (en) | 1995-11-02 |
Family
ID=22867373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/003014 WO1995029200A1 (en) | 1994-04-21 | 1995-03-13 | Easily degradable star-block copolymers |
Country Status (8)
Country | Link |
---|---|
US (1) | US5399666A (en) |
EP (1) | EP0756608A1 (en) |
JP (1) | JPH09512571A (en) |
CN (1) | CN1146775A (en) |
AU (1) | AU1988395A (en) |
CA (1) | CA2187625A1 (en) |
FI (1) | FI964217A0 (en) |
WO (1) | WO1995029200A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003037957A1 (en) * | 2001-11-02 | 2003-05-08 | Poly-Med, Inc. | Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
US6689116B1 (en) * | 1998-07-06 | 2004-02-10 | Sca Hygiene Products Ab | Diaper that includes weldable fastener devices |
US8632809B2 (en) | 2006-11-09 | 2014-01-21 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2123647C (en) * | 1993-06-11 | 2007-04-17 | Steven L. Bennett | Bioabsorbable copolymer and coating composition containing same |
US5925065A (en) * | 1993-06-11 | 1999-07-20 | United States Surgical Corporation | Coated gut suture |
US5639466A (en) * | 1994-02-24 | 1997-06-17 | Chronopol, Inc. | Method for packaging foodstuffs |
EP0786259B1 (en) * | 1996-01-19 | 2004-03-31 | United States Surgical Corporation | Absorbable polymer blends and surgical articles fabricated therefrom |
ATE302599T1 (en) * | 1996-05-24 | 2005-09-15 | Angiotech Pharm Inc | PREPARATIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISEASES OF THE BODY PASSAGES |
US8172897B2 (en) * | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US10028851B2 (en) * | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
US6240616B1 (en) * | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6177094B1 (en) | 1998-04-30 | 2001-01-23 | United States Surgical Corporation | Bioabsorbable blends and coating composition containing same |
ES2230780T3 (en) * | 1999-08-18 | 2005-05-01 | Christian Dr. Med. Jurgens | RESERVABLE COPOLILACTIDES AND ITS EMPLOYMENT. |
US6462169B1 (en) * | 1999-11-30 | 2002-10-08 | Poly-Med, Inc. | Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
EP1236753A1 (en) * | 2001-03-02 | 2002-09-04 | Hycail B.V. | Environmentally degradable polymeric compounds, their preparation and use as hot melt adhesive |
US7285304B1 (en) * | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7989018B2 (en) * | 2001-09-17 | 2011-08-02 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US6863683B2 (en) * | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
EP1334990A1 (en) * | 2002-02-06 | 2003-08-13 | Polyganics B.V. | DL-Lactide-epsilon-caprolactone copolymers |
US20060271168A1 (en) * | 2002-10-30 | 2006-11-30 | Klaus Kleine | Degradable medical device |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US8568469B1 (en) | 2004-06-28 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Stent locking element and a method of securing a stent on a delivery system |
US8241554B1 (en) | 2004-06-29 | 2012-08-14 | Advanced Cardiovascular Systems, Inc. | Method of forming a stent pattern on a tube |
US8747878B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device by controlling crystalline structure |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
US8747879B2 (en) * | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US7971333B2 (en) * | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US20060041102A1 (en) * | 2004-08-23 | 2006-02-23 | Advanced Cardiovascular Systems, Inc. | Implantable devices comprising biologically absorbable polymers having constant rate of degradation and methods for fabricating the same |
US9283099B2 (en) * | 2004-08-25 | 2016-03-15 | Advanced Cardiovascular Systems, Inc. | Stent-catheter assembly with a releasable connection for stent retention |
US7229471B2 (en) * | 2004-09-10 | 2007-06-12 | Advanced Cardiovascular Systems, Inc. | Compositions containing fast-leaching plasticizers for improved performance of medical devices |
US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
US7875233B2 (en) | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
US20060224226A1 (en) * | 2005-03-31 | 2006-10-05 | Bin Huang | In-vivo radial orientation of a polymeric implantable medical device |
US7381048B2 (en) * | 2005-04-12 | 2008-06-03 | Advanced Cardiovascular Systems, Inc. | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US7291166B2 (en) * | 2005-05-18 | 2007-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20060292690A1 (en) * | 2005-06-22 | 2006-12-28 | Cesco Bioengineering Co., Ltd. | Method of making cell growth surface |
US7658880B2 (en) * | 2005-07-29 | 2010-02-09 | Advanced Cardiovascular Systems, Inc. | Polymeric stent polishing method and apparatus |
US7297758B2 (en) * | 2005-08-02 | 2007-11-20 | Advanced Cardiovascular Systems, Inc. | Method for extending shelf-life of constructs of semi-crystallizable polymers |
US20070038290A1 (en) * | 2005-08-15 | 2007-02-15 | Bin Huang | Fiber reinforced composite stents |
US7476245B2 (en) * | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20070045255A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with an optimized process gas |
US9248034B2 (en) * | 2005-08-23 | 2016-02-02 | Advanced Cardiovascular Systems, Inc. | Controlled disintegrating implantable medical devices |
US20070045252A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with a process gas |
WO2007051252A1 (en) * | 2005-11-03 | 2007-05-10 | The University Of Melbourne | Porous polymeric materials and polymer particles for preparation thereof |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US20070148251A1 (en) * | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
CN100348640C (en) * | 2005-12-29 | 2007-11-14 | 上海交通大学 | Preparation method of glycosyl teminated functionalized polycaprolactone with different branch structure |
US20070151961A1 (en) * | 2006-01-03 | 2007-07-05 | Klaus Kleine | Fabrication of an implantable medical device with a modified laser beam |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US7951185B1 (en) | 2006-01-06 | 2011-05-31 | Advanced Cardiovascular Systems, Inc. | Delivery of a stent at an elevated temperature |
US20070179219A1 (en) * | 2006-01-31 | 2007-08-02 | Bin Huang | Method of fabricating an implantable medical device using gel extrusion and charge induced orientation |
US7964210B2 (en) * | 2006-03-31 | 2011-06-21 | Abbott Cardiovascular Systems Inc. | Degradable polymeric implantable medical devices with a continuous phase and discrete phase |
US20070254012A1 (en) * | 2006-04-28 | 2007-11-01 | Ludwig Florian N | Controlled degradation and drug release in stents |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US7761968B2 (en) * | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
US7951194B2 (en) | 2006-05-26 | 2011-05-31 | Abbott Cardiovascular Sysetms Inc. | Bioabsorbable stent with radiopaque coating |
US20130325104A1 (en) | 2006-05-26 | 2013-12-05 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
US7842737B2 (en) | 2006-09-29 | 2010-11-30 | Abbott Cardiovascular Systems Inc. | Polymer blend-bioceramic composite implantable medical devices |
US8343530B2 (en) * | 2006-05-30 | 2013-01-01 | Abbott Cardiovascular Systems Inc. | Polymer-and polymer blend-bioceramic composite implantable medical devices |
US7959940B2 (en) * | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
US20070282434A1 (en) * | 2006-05-30 | 2007-12-06 | Yunbing Wang | Copolymer-bioceramic composite implantable medical devices |
US20080058916A1 (en) * | 2006-05-31 | 2008-03-06 | Bin Huang | Method of fabricating polymeric self-expandable stent |
US20070281073A1 (en) * | 2006-06-01 | 2007-12-06 | Gale David C | Enhanced adhesion of drug delivery coatings on stents |
US8034287B2 (en) * | 2006-06-01 | 2011-10-11 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US8486135B2 (en) | 2006-06-01 | 2013-07-16 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from branched polymers |
US20070286941A1 (en) * | 2006-06-13 | 2007-12-13 | Bin Huang | Surface treatment of a polymeric stent |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US8333000B2 (en) | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9072820B2 (en) * | 2006-06-26 | 2015-07-07 | Advanced Cardiovascular Systems, Inc. | Polymer composite stent with polymer particles |
US20070299511A1 (en) * | 2006-06-27 | 2007-12-27 | Gale David C | Thin stent coating |
US8128688B2 (en) * | 2006-06-27 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Carbon coating on an implantable device |
US7794776B1 (en) | 2006-06-29 | 2010-09-14 | Abbott Cardiovascular Systems Inc. | Modification of polymer stents with radiation |
US7740791B2 (en) * | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
US20080009938A1 (en) * | 2006-07-07 | 2008-01-10 | Bin Huang | Stent with a radiopaque marker and method for making the same |
US7823263B2 (en) | 2006-07-11 | 2010-11-02 | Abbott Cardiovascular Systems Inc. | Method of removing stent islands from a stent |
US7757543B2 (en) * | 2006-07-13 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Radio frequency identification monitoring of stents |
US7998404B2 (en) * | 2006-07-13 | 2011-08-16 | Advanced Cardiovascular Systems, Inc. | Reduced temperature sterilization of stents |
US20080014244A1 (en) * | 2006-07-13 | 2008-01-17 | Gale David C | Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers |
US7794495B2 (en) * | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
US7886419B2 (en) * | 2006-07-18 | 2011-02-15 | Advanced Cardiovascular Systems, Inc. | Stent crimping apparatus and method |
US8016879B2 (en) * | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
US20080091262A1 (en) * | 2006-10-17 | 2008-04-17 | Gale David C | Drug delivery after biodegradation of the stent scaffolding |
US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
US7923022B2 (en) * | 2006-09-13 | 2011-04-12 | Advanced Cardiovascular Systems, Inc. | Degradable polymeric implantable medical devices with continuous phase and discrete phase |
US8099849B2 (en) | 2006-12-13 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Optimizing fracture toughness of polymeric stent |
FR2912752B1 (en) * | 2007-02-16 | 2012-10-05 | Arkema France | PROCESS FOR PREPARING A COPOLYMER OF AT LEAST ONE CYCLIC MONOMER |
FR2912751B1 (en) * | 2007-02-16 | 2012-07-13 | Arkema France | PROCESS FOR THE PREPARATION OF POLYLACTONES AND POLYLACTAMES |
US20080243228A1 (en) * | 2007-03-28 | 2008-10-02 | Yunbing Wang | Implantable medical devices fabricated from block copolymers |
US8262723B2 (en) | 2007-04-09 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polymer blends with star-block copolymers |
US20080269874A1 (en) * | 2007-04-30 | 2008-10-30 | Yunbing Wang | Implantable medical devices fabricated from polymers with radiopaque groups |
US7829008B2 (en) * | 2007-05-30 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Fabricating a stent from a blow molded tube |
US7959857B2 (en) * | 2007-06-01 | 2011-06-14 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US8293260B2 (en) * | 2007-06-05 | 2012-10-23 | Abbott Cardiovascular Systems Inc. | Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices |
US8202528B2 (en) * | 2007-06-05 | 2012-06-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices with elastomeric block copolymer coatings |
US20080306582A1 (en) * | 2007-06-05 | 2008-12-11 | Yunbing Wang | Implantable medical devices with elastomeric copolymer coatings |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US7901452B2 (en) * | 2007-06-27 | 2011-03-08 | Abbott Cardiovascular Systems Inc. | Method to fabricate a stent having selected morphology to reduce restenosis |
US7955381B1 (en) | 2007-06-29 | 2011-06-07 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical device with different types of bioceramic particles |
US8614286B2 (en) * | 2008-09-02 | 2013-12-24 | Ppg Industries Ohio, Inc. | Biomass derived radiation curable liquid coatings |
US20100055471A1 (en) * | 2008-09-02 | 2010-03-04 | Ppg Industries Ohio, Inc. | Waterborne polyurethane dispersion comprising biomass derived polyol and coatings comprising same |
US20100055467A1 (en) * | 2008-09-02 | 2010-03-04 | Ppg Industries Ohio, Inc. | Coating compositions comprising the reaction product of a biomass derived polyol and a lactide |
US9650540B2 (en) * | 2008-09-02 | 2017-05-16 | Ppg Industries Ohio, Inc. | Radiation curable coating compositions comprising a lactide reaction product |
US8076001B2 (en) * | 2008-09-02 | 2011-12-13 | Ppg Industries Ohio, Inc | Crosslinked coatings comprising lactide |
US20100055483A1 (en) * | 2008-09-02 | 2010-03-04 | Ppg Industries Ohio, Inc. | Biomass derived radiation curable liquid coatings |
US20100055468A1 (en) * | 2008-09-02 | 2010-03-04 | Ppg Industries Ohio, Inc. | Radiation curable coating compositions comprising a lactide reaction product |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
JP2012214599A (en) * | 2011-03-31 | 2012-11-08 | Research Institute Of Innovative Technology For The Earth | Room temperature moldable biodegradable polyester and method for producing the same |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
EA031068B1 (en) * | 2011-12-15 | 2018-11-30 | Тотал Ресерч & Технолоджи Фелай | Process for the preparation of copolymers comprising a lactic acid oligomer |
WO2014172261A1 (en) * | 2013-04-15 | 2014-10-23 | Kent State University | Biodegradable side chain liquid crystal elastomers: smart responsive scaffolds (srs) for tissue regeneration |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225521A (en) * | 1991-12-31 | 1993-07-06 | E. I. Du Pont De Nemours And Company | Star-shaped hydroxyacid polymers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1232285A (en) * | 1983-02-24 | 1988-02-02 | Linda A. Domeier | Polyester polyols and a process for their production |
US5028667A (en) * | 1989-09-29 | 1991-07-02 | E.I. Du Pont De Nemours And Company | Yttrium and rare earth compounds catalyzed lactone polymerization |
US5292859A (en) * | 1992-12-22 | 1994-03-08 | E. I. Du Pont De Nemours And Company | Rare earth metal coordination compounds as lactone polymerization catalysts |
US5210108A (en) * | 1992-07-29 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Degradable foam materials |
-
1994
- 1994-04-21 US US08/230,994 patent/US5399666A/en not_active Expired - Fee Related
-
1995
- 1995-03-13 CA CA002187625A patent/CA2187625A1/en not_active Abandoned
- 1995-03-13 WO PCT/US1995/003014 patent/WO1995029200A1/en not_active Application Discontinuation
- 1995-03-13 EP EP95912859A patent/EP0756608A1/en not_active Ceased
- 1995-03-13 CN CN95192679A patent/CN1146775A/en active Pending
- 1995-03-13 AU AU19883/95A patent/AU1988395A/en not_active Abandoned
- 1995-03-13 JP JP7527629A patent/JPH09512571A/en active Pending
-
1996
- 1996-10-18 FI FI964217A patent/FI964217A0/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225521A (en) * | 1991-12-31 | 1993-07-06 | E. I. Du Pont De Nemours And Company | Star-shaped hydroxyacid polymers |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689116B1 (en) * | 1998-07-06 | 2004-02-10 | Sca Hygiene Products Ab | Diaper that includes weldable fastener devices |
WO2003037957A1 (en) * | 2001-11-02 | 2003-05-08 | Poly-Med, Inc. | Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
US8632809B2 (en) | 2006-11-09 | 2014-01-21 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
Also Published As
Publication number | Publication date |
---|---|
FI964217A (en) | 1996-10-18 |
JPH09512571A (en) | 1997-12-16 |
EP0756608A1 (en) | 1997-02-05 |
CA2187625A1 (en) | 1995-11-02 |
US5399666A (en) | 1995-03-21 |
CN1146775A (en) | 1997-04-02 |
FI964217A0 (en) | 1996-10-18 |
AU1988395A (en) | 1995-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5399666A (en) | Easily degradable star-block copolymers | |
EP0667885B1 (en) | Rubber-modified polylactide and/or glycolide composition | |
US5424346A (en) | Biodegradable replacement of crystal polystyrene | |
US5320624A (en) | Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorbable surgical devices made therefrom | |
US5714551A (en) | High strength, melt processable, lactide-rich, poly (lactide-co-p-dioxanone) copolymers | |
Storey et al. | Methacrylate-endcapped poly (d, l-lactide-co-trimethylene carbonate) oligomers. Network formation by thermal free-radical curing | |
EP0636639B1 (en) | Copolymers of an aromatic anhydride and aliphatic ester | |
US6346599B1 (en) | Biodegradable lactone copolymers | |
US5824751A (en) | Biodegradable high molecular composition | |
EP0548284A1 (en) | Packaging thermoplastics from lactic acid | |
WO1997015609A9 (en) | Method for the synthesis of environmentally degradable block copolymers | |
US6297349B1 (en) | Condensation copolymers having supressed crystallinity | |
EP2558518A1 (en) | Thermoplastic composition formed from polylactic acid and elastomeric graft copolymer | |
EP0910598B1 (en) | High impact strength biodegradable material | |
US7652127B2 (en) | Absorbable copolyesters of poly(ethoxyethylene diglycolate) and glycolide | |
Furch et al. | Synthesis and characterisation of copolymers of methyl acrylate and poly (glycolide) macromonomers | |
MXPA96004958A (en) | Block copolymers in the form of star, easily degradab | |
Bagheri et al. | Synthesis and characterization of biodegradable random copolymers of L-lactide, glycolide and trimethylene carbonate | |
Mohammadi‐Rovshandeh et al. | Synthesis and characterization of ABA triblock and novel multiblock copolymers from ethylene glycol, l‐lactide, and ϵ‐caprolactone | |
FI102682B (en) | Impact biodegradable material | |
JPH1129628A (en) | Lactic acid-based copolyester having excellent bleedout resistance | |
MXPA00001926A (en) | Condensation copolymers having surpressed crystallinity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 95192679.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU JP KG KP KR KZ LK LR LT LV MD MG MN MX NO NZ PL RO RU SG SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995912859 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2187625 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1996/004958 Country of ref document: MX Ref document number: 964217 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1995912859 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1995912859 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995912859 Country of ref document: EP |